Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib with Bendamustine +/- Rituximab in Advanced Cancers
NCT01326702Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2011
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of veliparib in solid tumor, lymphoma, multiple myeloma (MM), sponsored by National Cancer Institute. Started Jul 2011; status: completed.
02
Drugs
veliparib
03
Conditions
solid tumorlymphomamultiple myeloma (MM)
Beyond the preview
Go deeper on NCT01326702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01326702.